CVRM Forum 2025

The Cardiovascular, Renal, and Metabolism (CVRM) Forum – 2025 is a specialized continuing professional development (CPD) event designed to equip healthcare professionals with the latest insights, clinical data, and multidisciplinary strategies in the management of interrelated cardio-renal-metabolic conditions.

Facilitated by a team of distinguished experts—a Cardiologist, Nephrologist, Endocrinologist, and Pharmacist—this summit promises to be an intellectually engaging and practice-transforming experience. Participants will explore the growing body of evidence supporting the early adoption of SGLT2 inhibitors (SGLT2i) across the continuum of cardiovascular, renal, and metabolic care, while also examining real-world implementation challenges and the science driving pharmaceutical innovation.

The event will combine didactic sessions, case-based discussions, and evidence-focused dialogue, fostering a comprehensive understanding of patient-centered management approaches across disciplines.

WHY YOU SHOULD ATTEND

This training presents an invaluable opportunity to:

1. Stay abreast of current evidence-based treatment guidelines and clinical trials shaping the future of CVRM care.

2. Gain a multidisciplinary perspective from seasoned specialists on integrated patient management.

3. Participate in interactive clinical case analyses of complex cardio-renal-metabolic presentations.

4. Understand the science behind pharmaceutical innovation, differentiating innovator molecules from generics.

5. Earn CPD points accredited by the Medical and Dental Council (MDC) through CES.

6. Network virtually with peers and experts, broadening professional and clinical perspectives.

SUMMARY OF TOPICS TO BE PRESENTED

i. Evidence-Based Clinical Practice: Early Adoption of SGLT2i in the Management of Type 2 Diabetes Mellitus (T2DM)

ii. Breaking the Clinical Inertia: The Gap in SGLT2i Use for Chronic Kidney Disease (CKD) Management

iii. Case-Based Discussion: Clinical Strategies in Managing Cardio-Renal Complicated Cases

iv. Innovator vs. Generic: Understanding the Science Behind Pharmaceutical Innovation

EVENT HIGHLIGHTS

1. Keynote presentations by top-tier clinicians and researchers.

2. Real-world case studies and multidisciplinary discussions.

3. Comprehensive exploration of SGLT2i evidence and treatment guidelines.

4. Interactive Q&A and polling sessions.

5. Access to presentation materials post-event.

6. Certificate of participation and CPD accreditation from MDC.

ORGANIZED BY

This will be a virtual event. It will be streamed LIVE on this page.

Date: Thurs, 30th October 2025

Time: 16:00 - 1815 GMT (4:00- 06:15 am Local Time) 

Target Audience: General Practitioners (GPs)

The agenda is available to download in the downloads section.

PARTICIPANT CONSENT AND DATA PRIVACY NOTICE

By registering for the “Cardiovascular, Renal, and Metabolism (CVRM) Summit – 2025”, you consent to participate in this training hosted by Continuous Education Services (CES) on behalf of AstraZeneca. Your registration will provide the necessary information to facilitate the event and issue CPD accreditation through the Medical and Dental Council (MDC).

CES is committed to protecting your personal information and will not share any personal data with AstraZeneca. Your data will only be shared with relevant regulatory bodies, such as the MDC, solely for the purpose of accrediting CPD points earned through this training.

Participants may opt out of the meeting at any time, and doing so requires no further action. CES respects your privacy and ensures that all participation and data will be treated with the highest level of confidentiality.